Spravato for Depression

Spravato, known generically as esketamine, is a nasal spray approved for use in treating depression, especially in adults who have not responded to other treatments. At Brandon TMS and Psychiatry, we incorporate Spravato into our therapeutic offerings to provide an alternative solution for those experiencing treatment-resistant depression. This medication represents a significant advancement in the field of mental health, offering new hope to those who need it most. Contact us.

How Spravato Helps With Depression Treatment

Spravato acts differently from traditional antidepressants. Here’s how it can change the treatment landscape for patients:

Rapid Acting: Spravato can alleviate depressive symptoms much faster than many other antidepressants, with some patients feeling better within hours of the first dose.
Targeted Therapy: It targets the NMDA receptor in the brain, a different approach than most antidepressants, which typically affect serotonin or norepinephrine.
Administration and Monitoring: Treatment involves administration under medical supervision in a healthcare setting to monitor its effects and ensure patient safety.

What is Spravato?

This video explains what Spravato is.

Treatment Process with Spravato at Brandon TMS and Psychiatry

Here’s what patients can expect when undergoing treatment with Spravato:

Initial Consultation: Professional evaluation to determine if Spravato is the right treatment option.
Supervised Administration: Spravato is administered twice a week for an initial period in our office, under the supervision of healthcare professionals.
Ongoing Assessment: Continuous monitoring of symptoms and side effects to adjust the treatment plan as necessary.

Benefits of Using Spravato for Depression

Patients choosing Spravato may experience several benefits:

Quick Symptom Improvement: Many report rapid relief from depressive symptoms, which can be life-changing for those who have struggled with long-term depression.
New Treatment Avenue: Offers a new option for patients who have tried and not responded to multiple other antidepressants.
Comprehensive Care: At Brandon TMS and Psychiatry, Spravato is part of a broader, individualized care plan that includes other therapies and support.

Spravato presents a promising new avenue for depression treatment, particularly for those who have not found relief with traditional therapies. Our practice is committed to providing this innovative treatment, helping to restore hope and improve the quality of life for our patients.